First Trust Advisors
ALXN

First Trust Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-672,646
Closed -$124M 2708
2021
Q2
$124M Sell
672,646
-46,025
-6% -$8.46M 0.13% 201
2021
Q1
$110M Sell
718,671
-49,492
-6% -$7.57M 0.13% 193
2020
Q4
$120M Sell
768,163
-1,373,462
-64% -$215M 0.16% 160
2020
Q3
$245M Buy
2,141,625
+178,489
+9% +$20.4M 0.39% 43
2020
Q2
$220M Buy
1,963,136
+995,688
+103% +$112M 0.38% 40
2020
Q1
$86.9M Buy
967,448
+119,603
+14% +$10.7M 0.2% 115
2019
Q4
$91.7M Buy
847,845
+187,762
+28% +$20.3M 0.16% 149
2019
Q3
$64.6M Sell
660,083
-317,932
-33% -$31.1M 0.12% 215
2019
Q2
$128M Buy
978,015
+63,824
+7% +$8.36M 0.24% 78
2019
Q1
$124M Buy
914,191
+12,919
+1% +$1.75M 0.25% 81
2018
Q4
$87.7M Buy
901,272
+17,015
+2% +$1.66M 0.21% 93
2018
Q3
$123M Buy
884,257
+343,838
+64% +$47.8M 0.23% 81
2018
Q2
$67.1M Buy
540,419
+58,997
+12% +$7.32M 0.14% 144
2018
Q1
$53.7M Sell
481,422
-20,187
-4% -$2.25M 0.12% 171
2017
Q4
$60M Buy
501,609
+176,251
+54% +$21.1M 0.14% 144
2017
Q3
$45.6M Sell
325,358
-2,595
-0.8% -$364K 0.12% 188
2017
Q2
$39.9M Buy
327,953
+41,384
+14% +$5.04M 0.11% 219
2017
Q1
$34.7M Buy
286,569
+17,347
+6% +$2.1M 0.1% 251
2016
Q4
$32.9M Buy
269,222
+11,299
+4% +$1.38M 0.1% 238
2016
Q3
$31.6M Buy
257,923
+25,148
+11% +$3.08M 0.09% 253
2016
Q2
$27.2M Sell
232,775
-182,350
-44% -$21.3M 0.09% 296
2016
Q1
$57.8M Sell
415,125
-369,106
-47% -$51.4M 0.19% 109
2015
Q4
$150M Sell
784,231
-26,908
-3% -$5.13M 0.39% 33
2015
Q3
$127M Buy
811,139
+14,868
+2% +$2.33M 0.37% 38
2015
Q2
$144M Sell
796,271
-157,408
-17% -$28.5M 0.37% 40
2015
Q1
$165M Buy
953,679
+224,852
+31% +$39M 0.49% 19
2014
Q4
$135M Buy
728,827
+25,874
+4% +$4.79M 0.45% 15
2014
Q3
$117M Sell
702,953
-65,610
-9% -$10.9M 0.46% 16
2014
Q2
$120M Buy
768,563
+92,589
+14% +$14.5M 0.5% 8
2014
Q1
$103M Buy
675,974
+107,418
+19% +$16.3M 0.45% 16
2013
Q4
$75.6M Buy
568,556
+174,335
+44% +$23.2M 0.37% 24
2013
Q3
$45.8M Buy
394,221
+101,534
+35% +$11.8M 0.25% 66
2013
Q2
$27M Buy
+292,687
New +$27M 0.18% 130